BackGenerate Biomedicines Overview

Generate Biomedicines Net Tangible Assets

Generate Biomedicines's net tangible assets is $510M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$514.80M

Peer average / median

Loading

Generate Biomedicines Net Tangible Assets History

Loading

Generate Biomedicines vs. peers: Net Tangible Assets Comparison

Loading

Generate Biomedicines Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Generate Biomedicines (GENB) FAQ

As of the most recent data (March 2026), GENB shows a net tangible assets of $510M. Scroll down for historical charts and peer comparison views.

Tracking GENB's net tangible assets over time shows whether Generate Biomedicines is scaling, shrinking, or reshaping that part of the business. The current reading is $510M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Generate Biomedicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $510M) with ownership activity and broader fundamentals.